Manipulation of the complement system for benefit in sepsis

Critical Care Research and Practice

Volumn 2012, Issue , 2012, Pages

  Ward, Peter A ^a   Guo, Ren Feng ^a   Riedemann, Niels C ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866259286     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2012/427607     Document Type: Article

References (29)

1. Ward P. A., The harmful Role of C5a on innate immunity in sepsis. Journal of Innate Immunity 2010 2 5 439 445 2-s2.0-77956057326 10.1159/000317194
2. Huber-Lang M. S., Younkin E. M., Sarma J. V., McGuire S. R., Lu K. T., Guo R. F., Padgaonkar V. A., Curnutte J. T., Erickson R., Ward P. A., Complement-induced impairment of innate immunity during sepsis. Journal of Immunology 2002 169 6 3223 3231 2-s2.0-0037105426 (Pubitemid 35013169)
3. Riedemann N. C., Guo R. F., Neff T. A., Laudes I. J., Keller K. A., Sarma V. J., Markiewski M. M., Mastellos D., Strey C. W., Pierson C. L., Lambris J. D., Zetoune F. S., Ward P. A., Increased C5a receptor expression in sepsis. Journal of Clinical Investigation 2002 110 1 101 108 2-s2.0-0036304968 10.1172/JCI200215409 (Pubitemid 34743470)
4. Rittirsch D., Huber-Lang M. S., Flierl M. A., Ward P. A., Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols 2009 4 1 31 36 2-s2.0-61449154547 10.1038/nprot.2008.214
5. Rittirsch D., Flierl M. A., Nadeau B. A., Day D. E., Huber-Lang M., Mackay C. R., Zetoune F. S., Gerard N. P., Cianflone K., Köhl J., Gerard C., Sarma J. V., Ward P. A., Functional roles for C5a receptors in sepsis. Nature Medicine 2008 14 5 551 557 2-s2.0-43249098418 10.1038/nm1753 (Pubitemid 351655216)
6. Huber-Lang M., Sarma J. V., Zetoune F. S., Rittirsch D., Neff T. A., McGuire S. R., Lambris J. D., Warner R. L., Flierl M. A., Hoesel L. M., Gebhard F., Younger J. G., Drouin S. M., Wetsel R. A., Ward P. A., Generation of C5a in the absence of C3: a new complement activation pathway. Nature Medicine 2006 12 6 682 687 2-s2.0-33744987414 10.1038/nm1419 (Pubitemid 43865238)
7. Stevens J. H., O'Hanley P., Shapiro J. M., Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. Journal of Clinical Investigation 1986 77 6 1812 1816 (Pubitemid 16062634)
8. Hangen D. H., Stevens J. H., Satoh P. S., Hall E. W., O'Hanley P. T., Raffin T. A., Complement levels in septic primates treated with anti-C5a antibodies. Journal of Surgical Research 1989 46 3 195 199 2-s2.0-0024598582 (Pubitemid 19098325)
9. Höpken U., Mohr M., Strüber A., Montz H., Burchardi H., Götze O., Oppermann M., Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. European Journal of Immunology 1996 26 5 1103 1109 10.1002/eji.1830260522 (Pubitemid 26158509)
10. Mohr M., mmohr@gwdg.de Höpken U., Oppermann M., Mathes C., Goldmann K., Siever S., Götze O., Burchardi H., Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis. European Journal of Clinical Investigation 1998 28 3 227 234 10.1046/j.1365-2362.1998.00260.x (Pubitemid 28168297)
11. Smedegard G., Cui L., Hugli T. E., Endotoxin-induced shock in the rat. A role for C5a. American Journal of Pathology 1989 135 3 489 497 2-s2.0-0024450510 (Pubitemid 19246207)
12. Czermak B. J., Sarma V., Pierson C. L., Warner R. L., Huber-Lang M., Bless N. M., Schmal H., Friedl H. P., Ward P. A., Protective effects of C5a blockade in sepsis. Nature Medicine 1999 5 7 788 792 2-s2.0-0033052453 10.1038/10512 (Pubitemid 29318613)
13. Huber-Lang M. S., Sarma J. V., McGuire S. R., Lu K. T., Guo R. F., Padgaonkar V. A., Younkin E. M., Laudes I. J., Riedemann N. C., Younger J. G., Ward P. A., Protective effects of anti-C5a peptide antibodies in experimental sepsis. The FASEB Journal 2001 15 3 568 570 2-s2.0-0035286776
14. Huber-Lang M., Sarma V. J., Lu K. T., McGuire S. R., Padgaonkar V. A., Guo R. F., Younkin E. M., Kunkel R. G., Ding J., Erickson R., Curnutte J. T., Ward P. A., Role of C5a in multiorgan failure during sepsis. Journal of Immunology 2001 166 2 1193 1199 2-s2.0-0035863922 (Pubitemid 32060279)
15. Allegretti M., Moriconi A., Beccari A. R., Di Bitondo R., Bizzarri C., Bertini R., Colotta F., Targeting C5a: recent advances in drug discovery. Current Medicinal Chemistry 2005 12 2 217 236 2-s2.0-11844277629 (Pubitemid 40089835)
16. Hiramatsu M., Hotchkiss R. S., Karl I. E., Buchman T. G., Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and GUT by an endotoxin and TNF- independent pathway. Shock 1997 7 4 247 253 2-s2.0-0031110570 (Pubitemid 127654275)
17. Hotchkiss R. S., Swanson P. E., Cobb J. P., Jacobson A., Buchman T. G., Karl I. E., Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-celldeficient mice. Critical Care Medicine 1997 25 8 1298 1307 2-s2.0-0030739250 10.1097/00003246-199708000-00015 (Pubitemid 27347292)
18. + T lymphocytes in humans. Journal of Immunology 2001 166 11 6952 6963 2-s2.0-0035338993 (Pubitemid 32467243)
19. Hotchkiss R. S., Chang K. C., Swanson P. E., Tinsley K. W., Hui J. J., Klender P., Xanthoudakis S., Roy S., Black C., Grimm E., Aspiotis R., Han Y., Nicholson D. W., Karl I. E., Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nature Immunology 2000 1 6 496 501 2-s2.0-5944251623
20. Guo R. F., Huber-Lang M., Wang X., Sarma V., Padgaonkar V. A., Craig R. A., Riedemann N. C., McClintock S. D., Hlaing T., Shi M. M., Ward P. A., Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. Journal of Clinical Investigation 2000 106 10 1271 1280 2-s2.0-0033692759
21. Riedemann N. C., Guo R. F., Laudes I. J., Keller K., Sarma V. J., Padgaonkar V., Zetoune F. S., Ward P. A., C5a receptor and thymocyte apoptosis in sepsis. The FASEB Journal 2002 16 8 887 888 2-s2.0-0036615932
22. Hammerschmidt D. E., Weaver L. J., Hudson L. D., Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. The Lancet 1980 1 8175 947 949 2-s2.0-0018857939 (Pubitemid 10150800)
23. Solomkin J. S., Jenkins M. K., Nelson R. D., Chenoweth D., Simmons R. L., Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 1981 90 2 319 327 2-s2.0-0019446122 (Pubitemid 11047245)
24. Caliezi C., Zeerleder S., Redondo M., Regli B., Rothen H. U., Zürcher-Zenklusen R., Rieben R., Devay J., Hack C. E., Lämmle B., Wuillemin W. A., C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Critical Care Medicine 2002 30 8 1722 1728 2-s2.0-0036348546 (Pubitemid 34879581)
25. Van Dyke T. E., Role of the neutrophil in oral disease: receptor deficiency in leukocytes from patients with juvenile periodontitis. Reviews of Infectious Diseases 1985 7 3 419 425 2-s2.0-0022055135
26. Kelly R. J., richardkelly@nhs.net Hill A., Arnold L. M., Brooksbank G. L., Richards S. J., Cullen M., Mitchell L. D., Cohen D. R., Gregory W. M., Hillmen P., Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 2011 117 25 6786 6792 10.1182/blood-2011-02-333997
27. Flierl M. A., Rittirsch D., Nadeau B. A., Day D. E., Zetoune F. S., Sarma J. V., Huber-Lang M. S., Ward P. A., Functions of the complement components C3 and C5 during sepsis. FASEB Journal 2008 22 10 3483 3490 2-s2.0-54049102451 10.1096/fj.08-110595
28. Fredslund F., Laursen N. S., Roversi P., Jenner L., Oliveira C. L. P., Pedersen J. S., Nunn M. A., Lea S. M., Discipio R., Sottrup-Jensen L., Andersen G. R., Structure of and influence of a tick complement inhibitor on human complement component 5. Nature Immunology 2008 9 7 753 760 2-s2.0-45549085597 10.1038/ni.1625 (Pubitemid 351859158)
29. Sheridan C., TeGenero fiasco prompts regulatory rethink. Nature Biotechnology 2006 24 5 475 476 2-s2.0-33646540121 10.1038/nbt0506-475